Macomics secures £4.24m to accelerate macrophage-based therapeutics portfolio

29th July 2021 Uncategorised 0

The company was co-founded in 2019 by Jeffrey Pollard and Luca Cassetta of the University of Edinburgh

More: Macomics secures £4.24m to accelerate macrophage-based therapeutics portfolio
Source: News